Related references
Note: Only part of the references are listed.Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma
Anna C. H. Willemsen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC
Jhanelle E. Gray et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma
N. Chargi et al.
ORAL ONCOLOGY (2020)
Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy
Chris Burtin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Management of Cancer Cachexia: ASCO Guideline
Eric J. Roeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Body composition changes in patients with head and neck cancer under active treatment: a scoping review
Barbara Ferrao et al.
SUPPORTIVE CARE IN CANCER (2020)
Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States
Danielle F. Eytan et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2019)
The experience among patients with multiple dental loss as a consequence of treatment for head and neck cancer: A qualitative study
Roisin S. Parahoo et al.
JOURNAL OF DENTISTRY (2019)
Prognostic Value of Sarcopenia in Lung Cancer A Systematic Review and Meta-analysis
Ming Yang et al.
CHEST (2019)
Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung cancer
Karin J. C. Sanders et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2019)
Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review
G. F. P. Aleixo et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer
J. H. R. J. Degens et al.
LUNG CANCER (2019)
Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis
Frank Griesinger et al.
LUNG CANCER (2019)
Masticatory function and related factors after oral oncological treatment: A 5-year prospective study
Reilly J. de Groot et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis
Huaiying Su et al.
CANCER IMAGING (2019)
Combined Chemoradiotherapy-induced Weight Loss Decreases Survival in Locally Advanced Non-small Cell Lung Cancer Patients
Yi-Jun Kim et al.
IN VIVO (2019)
Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging
Ahmed Salem et al.
CLINICAL LUNG CANCER (2018)
Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma
Carryn M. Anderson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization
Cecilia Mouronte-Roibas et al.
RESPIRATION (2018)
Radiation, inflammation and the immune response in cancer
Kelly J. McKelvey et al.
MAMMALIAN GENOME (2018)
Longitudinal Body Composition Changes and the Importance of Fat-Free Mass Index in Locally Advanced Nasopharyngeal Carcinoma Patients Undergoing Concurrent Chemoradiotherapy
Huiping Ding et al.
INTEGRATIVE CANCER THERAPIES (2018)
Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
Jeffrey S. Damrauer et al.
EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY (2018)
European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer
Dirk De Ruysscher et al.
RADIOTHERAPY AND ONCOLOGY (2017)
HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer
Young-Suk Jung et al.
ONCOTARGET (2017)
Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC
Karin J. C. Sanders et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Immunohistochemical pattern analysis of squamous cell carcinoma: Lung primary and metastatic tumors of head and neck
Junji Ichinose et al.
LUNG CANCER (2016)
Prevalence and management of pulmonary comorbidity in patients with lung and head and neck cancer
Magnus Gottlieb et al.
ACTA ONCOLOGICA (2015)
Incidence of Head and Neck Squamous Cell Carcinoma Among Subjects at High Risk of Lung Cancer: Results From the Pittsburgh Lung Screening Study
Ronak Dixit et al.
CANCER (2015)
Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma
Olga C. J. Schuurbiers et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Mechanisms of cisplatin-induced muscle atrophy
Hiroyasu Sakai et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Evidence and Mechanisms of Fat Depletion in Cancer
Maryam Ebadi et al.
NUTRIENTS (2014)
Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer
Celine M. H. Op Den Kamp et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. Vansteenkiste et al.
ANNALS OF ONCOLOGY (2013)
Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review
Jacqueline A. E. Langius et al.
CLINICAL NUTRITION (2013)
Impact of Weight Change During the Course of Concurrent Chemoradiation Therapy on Outcomes in Stage IIIB Non-Small Cell Lung Cancer Patients: Retrospective Analysis of 425 Patients
Erkan Topkan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
New Normative Values for Handgrip Strength: Results From the UK Biobank
Martijn A. Spruit et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2013)
Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer The Importance of Smoking and Timing of Diagnosis
Helen A. Powell et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study
Seema Sethi et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4
Tineke W. H. Meijer et al.
LUNG CANCER (2012)
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity
E. C. J. Phernambucq et al.
ANNALS OF ONCOLOGY (2011)
Comparison of Platinum-Based Chemotherapy in Patients Older and Younger than 70 Years An Analysis of Southwest Oncology Group Trials 9308 and 9509
Elizabeth M. Blanchard et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
Pierre Blanchard et al.
RADIOTHERAPY AND ONCOLOGY (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
James A. Bonner et al.
LANCET ONCOLOGY (2010)
DEVELOPMENT AND EXTERNAL VALIDATION OF PROGNOSTIC MODEL FOR 2-YEAR SURVIVAL OF NON-SMALL-CELL LUNG CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY
Cary Dehing-Oberije et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer:: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study
P Fournel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
WQ Gan et al.
THORAX (2004)
Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98y
Y Schutz et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Share Paper
